Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development

Abstract

Prostate cancer (PCa) is by far the most commonly diagnosed cancer in men worldwide. Despite sensitivity to androgen deprivation, patients with advanced disease eventually develop resistance to therapy and may die of metastatic castration-resistant prostate cancer (mCRPC). A key challenge in the management of PCa is the clinical heterogeneity that is hard to predict using existing biomarkers. Defining molecular biomarkers for PCa that can reliably aid in diagnosis and distinguishing patients who require aggressive therapy from those who should avoid overtreatment is a significant unmet need. Mechanisms underlying the development of PCa are not confined to cancer epithelial cells, but also involve the tumor microenvironment. The crosstalk between epithelial cells and stroma in PCa has been shown to play an integral role in disease progression and metastasis. A number of key markers of reactive stroma has been identified including stem/progenitor cell markers, stromal-derived mediators of inflammation, regulators of angiogenesis, connective tissue growth factors, wingless homologs (Wnts), and integrins. Here, we provide a synopsis of the stromal-epithelial crosstalk in PCa focusing on the relevant molecular biomarkers pertaining to the tumor microenvironment and their role in diagnosis, prognosis, and therapy development.

Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer

“…One potential explanation for these discrepancies is heterogeneity of PSMA expression ( Figure 4 ). Immunohistochemistry studies of mCRPC lesions have noted significant inter- and intrapatient heterogeneity of PSMA expression [ 45 ]. An example of heterogeneity in a case of prostate cancer is illustrated in Figure 5 .…”

Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment

“…100 Due to their importance for disease progression and modulation of cancer-related processes such as inflammation and angiogenesis, stromal factors were proposed as molecular markers for diagnosis, prognosis, and treatment selection in prostate cancer. 101 Proteases play an important role within the CSC niches. Expressed and/or released either by cancer (stem) cells or by other cells of the niche, some proteases, such as cathepsins, are activated by the hypoxic and acidified TME.…”

Drosophila Accessory Gland: A Complementary In Vivo Model to Bring New Insight to Prostate Cancer

“…Moreover, the fact that these cells were cultured for years may have induced cell derivation and altered their initial representative nature of prostate cancer. Finally, complex cellular interactions in the tumor microenvironment are essential for cancer initiation and progression, and traditional bi-dimensional cell culture (2-D), where only one type of cell grows as a monolayer, does not model this rich environment [ 38 , 39 ].…”